Five Oceans Advisors’s GSK GSK Stock Holding History

Five Oceans Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$302K	Hold	6,261	–	–	0.12%	122
2026 Q2	$328K	Hold	6,261	–	–	0.11%	132
2026 Q1	$346K	Hold	6,261	–	–	0.13%	100
2025 Q4	$307K	Hold	6,261	–	–	0.11%	116
2025 Q3	$270K	Sell	6,261 -42	-0.7%	-$1.64K	0.1%	133
2025 Q2	$242K	Buy	6,303 +620	+11%	+$23.7K	0.1%	151
2025 Q1	$220K	Buy	+5,683	New	+$208K	0.11%	152
2024 Q4	–	Sell	-6,742	Closed	-$276K	–	187
2024 Q3	$276K	Sell	6,742 -1,224	-15%	-$50.1K	0.13%	133
2024 Q2	$307K	Buy	+7,966	New	+$335K	0.16%	108
2023 Q1	–	Sell	-5,846	Closed	-$205K	–	158
2022 Q4	$205K	Buy	+5,846	New	+$195K	0.14%	135
2022 Q3	–	Sell	-5,393	Closed	-$293K	–	138
2022 Q2	$293K	Buy	+5,393	New	+$298K	0.22%	90

Other funds holding GSK

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Five Oceans Advisors's GSK Position: Q3 2026 in Review

Five Oceans Advisors held its GSK (GSK) position steady in Q3 2026 at 6,261 shares worth $302K. The position accounts for 0.12% of the portfolio, ranked #122.

Five Oceans Advisors first reported a position in GSK in Q2 2022 and has held it in 11 quarters since. The position peaked at $346K in Q1 2026. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Five Oceans Advisors held 6,261 shares of GSK worth $302K as of Q3 2026.
Five Oceans Advisors left its GSK share count unchanged in Q3 2026.
GSK made up 0.12% of Five Oceans Advisors's portfolio in Q3 2026, its #122 holding.
Five Oceans Advisors first reported a position in GSK in Q2 2022 and has held it in 11 quarters since.
Five Oceans Advisors's GSK position peaked at $346K in Q1 2026.
266 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Five Oceans Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.